Nearly half of people with MS have sexual problems, and these are linked to disability, mood, bladder/bowel issues, smoking, and hormone changes but can improve with careful, whole-person care.
About 47% of people with MS in the study reported sexual dysfunction, meaning problems with desire, arousal, or sexual activity. People who had more physical disability, depression, or bladder and bowel problems were more likely to have sexual difficulties. Those who had ever smoked had higher chances of sexual problems, while people on disease-modifying treatments had lower chances. People with sexual problems also reported worse quality of life and did less physical activity, showing the problem affects daily life. Blood tests showed hormone differences in women with sexual problems and a sperm-related hormone change in men, which suggests body chemistry can play a role too.
People with MS should care because sexual problems are common and can make daily life, relationships, and mood worse — like how a leaky tire makes a car ride rough. Caregivers and partners should know these issues are real and not just 'in the person's head,' so they can offer support and seek help together. Healthcare providers should screen for sexual problems, especially when patients have more disability, mood issues, or bladder/bowel trouble, because spotting them early can lead to better care. Smoking cessation and staying active may help, so making small lifestyle changes could reduce risk, similar to how quitting smoking helps lung health. Treatments for MS and checking hormones may lower risk or point to targeted therapies, so talking with your care team can identify next steps.
This study shows links but cannot prove one thing causes another — for example, we don't know if hormone changes cause sexual problems or result from them. The group studied may not represent everyone with MS, so results might differ by age, duration of MS, or other health conditions. Because sexual health is personal and affected by many factors, any advice should be tailored by your care team to your situation.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More5/1/2026
Study finds a brain‑seeking CD4 killer cell tied to MS and CMV exposure that may resist some treatme
Read More5/1/2026
Study shows after optic neuritis the ganglion cell layer (GCL) loses more tissue than the inner plex
Read More5/1/2026
Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in
Read More5/1/2026
Study finds specific spinal fluid proteins tied to early nerve damage in active MS, highlighting imm
Read More5/1/2026
Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like European journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.